Phreesia, Inc. (PHR) Financial Ratios
9 years of historical data (2018–2026) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
23.35
↓-32% vs avg
5yr avg: 34.40
30Y Low34.4·High34.4
P/FCF
↓
8.14
↓-92% vs avg
5yr avg: 104.93
30Y Low12.2·High197.7
P/B Ratio
↓
1.63
↓-67% vs avg
5yr avg: 4.95
30Y Low2.4·High9.8
ROE
↑
0.8%
↓+102% vs avg
5yr avg: -31.5%
30Y Low-51%·High1%
Debt/EBITDA
4.12
+0% vs avg
5yr avg: 4.12
30Y Low4.1·High15.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PHR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Phreesia, Inc. trades at 237.9x earnings, 34% below its 5-year average of 358.1x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 975%. On a free-cash-flow basis, the stock trades at 8.1x P/FCF, 92% below the 5-year average of 104.9x.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $551M | $826M | $1.6B | $1.4B | $2.0B | $1.6B | $2.6B | $629M | — | — |
| Enterprise Value | $580M | $854M | $1.6B | $1.3B | $1.8B | $1.3B | $2.4B | $563M | — | — |
| P/E Ratio → | 237.87 | 358.13 | — | — | — | — | — | — | — | — |
| P/S Ratio | 1.15 | 1.72 | 3.90 | 3.90 | 7.00 | 7.30 | 17.35 | 5.04 | — | — |
| P/B Ratio | 1.63 | 2.45 | 6.19 | 5.53 | 6.83 | 3.73 | 9.80 | 6.18 | — | — |
| P/FCF | 8.14 | 12.20 | 197.66 | — | — | — | — | — | — | — |
| P/OCF | 7.00 | 10.48 | 50.62 | — | — | — | 892.82 | 761.91 | — | — |
P/E links to full P/E history page with 30-year chart
PHR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Phreesia, Inc.'s enterprise value stands at 23.3x EBITDA, 32% below its 5-year average of 34.4x. The Healthcare sector median is 14.2x, placing the stock at a 64% premium on an enterprise-value basis.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.78 | 3.75 | 3.69 | 6.40 | 5.90 | 15.98 | 4.51 | — | — |
| EV / EBITDA | 23.35 | 34.40 | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | 12.62 | 189.65 | — | — | — | — | — | — | — |
PHR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Phreesia, Inc. earns an operating margin of -1.4%. Operating margins have expanded from -38.3% to -1.4% over the past 3 years, signaling improving operational efficiency. ROE of 0.8% is modest.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 67.9% | 67.9% | 65.2% | 61.1% | 61.8% | 64.8% | 64.2% | 63.0% | 62.7% |
| Operating Margin | -1.4% | -1.4% | -13.8% | -38.3% | -62.8% | -54.8% | -17.3% | -12.3% | -9.5% | -18.2% |
| Net Profit Margin | 0.5% | 0.5% | -13.9% | -38.4% | -62.7% | -55.4% | -18.4% | -16.3% | -15.1% | -22.8% |
Return on Capital
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.8% | 0.8% | -22.7% | -50.8% | -50.0% | -34.7% | -14.9% | -19.9% | — | — |
| ROA | 0.4% | 0.4% | -15.4% | -37.0% | -40.7% | -28.8% | -11.2% | -18.6% | -25.9% | -31.8% |
| ROIC | -1.8% | -1.8% | -23.3% | -69.1% | -110.5% | -98.4% | -40.9% | -32.4% | — | — |
| ROCE | -1.8% | -1.8% | -21.7% | -49.5% | -49.2% | -33.5% | -13.0% | -19.8% | -29.9% | -45.3% |
PHR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Phreesia, Inc. carries a Debt/EBITDA ratio of 4.1x, which is highly leveraged (28% above the sector average of 3.2x). Net debt stands at $29M ($102M total debt minus $74M cash).
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.30 | 0.30 | 0.07 | 0.05 | 0.03 | 0.04 | 0.05 | 0.23 | — | — |
| Debt / EBITDA | 4.12 | 4.12 | — | — | — | — | — | — | 15.37 | — |
| Net Debt / Equity | — | 0.08 | -0.25 | -0.30 | -0.58 | -0.71 | -0.78 | -0.65 | — | — |
| Net Debt / EBITDA | 1.15 | 1.15 | — | — | — | — | — | — | 14.64 | — |
| Debt / FCF | — | 0.42 | -8.01 | — | — | — | — | — | — | — |
| Interest Coverage | -0.29 | -0.29 | -22.78 | -72.00 | -123.50 | -100.44 | -15.07 | -6.25 | -2.71 | -4.00 |
PHR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.53x means Phreesia, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.78x to 1.53x over the past 3 years.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | 1.53 | 1.78 | 1.78 | 3.32 | 5.65 | 4.95 | 3.72 | 1.18 | 1.44 |
| Quick Ratio | 1.53 | 1.53 | 1.78 | 1.77 | 3.31 | 5.62 | 4.79 | 3.53 | 1.12 | 1.37 |
| Cash Ratio | 0.40 | 0.40 | 0.74 | 0.79 | 2.24 | 4.59 | 3.98 | 2.55 | 0.06 | 0.42 |
| Asset Turnover | — | 0.72 | 1.08 | 0.96 | 0.76 | 0.43 | 0.46 | 0.79 | 1.69 | 1.40 |
| Inventory Turnover | — | — | — | 161.47 | 103.47 | 49.57 | 5.86 | 6.50 | 22.12 | 18.16 |
| Days Sales Outstanding | — | 117.44 | 64.01 | 66.45 | 66.78 | 68.92 | 71.32 | 64.29 | 96.07 | 56.28 |
PHR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Phreesia, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 0.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 2.4% | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.4% | 0.3% | — | — | — | — | — | — | — | — |
| FCF Yield | 12.3% | 8.2% | 0.5% | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.9% | 1.0% | 0.6% | 0.2% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.9% | 1.0% | 0.6% | 0.2% | 2.4% | — | — |
| Shares Outstanding | — | $61M | $58M | $55M | $52M | $50M | $40M | $20M | $2M | $2M |
Peer Comparison
Compare PHR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PHRYou | $551M | 237.9 | 23.3 | 8.1 | 67.9% | -1.4% | 0.8% | -1.8% | 4.1 |
 HCAT | $127M | -0.7 | 17.2 | — | 33.5% | -11.6% | -58.3% | -6.1% | 11.9 |
 DOCS | $4B | 20.5 | 16.5 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 |
 GDRX | $891M | 30.1 | 4.0 | 5.4 | 92.8% | 11.0% | 4.5% | 10.6% | 0.3 |
 VEEV | $25B | 28.2 | 19.7 | 17.9 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
 INVA | $2B | 6.9 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 TDOC | $1B | -6.6 | 16.2 | 4.8 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 AMWL | $137M | -1.4 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 PGNY | $2B | 40.4 | 21.8 | 10.7 | 23.6% | 6.6% | 12.5% | 18.1% | 0.3 |
 CLOV | $3B | -30.2 | — | — | 18.5% | -4.4% | -26.3% | -34.0% | — |
 LFST | $4B | 460.3 | 43.7 | 32.4 | 28.5% | 1.8% | 0.7% | 1.2% | 2.4 |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 9 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
PHR — Frequently Asked Questions
Quick answers to the most common questions about buying PHR stock.
What is Phreesia, Inc.'s P/E ratio?
Phreesia, Inc.'s current P/E ratio is 237.9x. This places it at the 50th percentile of its historical range.
What is Phreesia, Inc.'s EV/EBITDA?
Phreesia, Inc.'s current EV/EBITDA is 23.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 34.4x.
What is Phreesia, Inc.'s ROE?
Phreesia, Inc.'s return on equity (ROE) is 0.8%. The historical average is -27.5%.
Is PHR stock overvalued?
Based on historical data, Phreesia, Inc. is trading at a P/E of 237.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Phreesia, Inc.'s profit margins?
Phreesia, Inc. has 67.9% gross margin and -1.4% operating margin.
How much debt does Phreesia, Inc. have?
Phreesia, Inc.'s Debt/EBITDA ratio is 4.1x, indicating high leverage. A ratio above 4x may signal elevated financial risk.